Research explores the complexities of diagnosing and treating stiff-person syndrome, emphasizing the uncertain role of GAD antibodies and the promise of novel therapies.
Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq | Psychedelic Invest
Incannex Healthcare Limited (NASDAQ: IXHL / ASX: IHL), is pleased to announce its intention to redomicile from Australia to the United States via proposed schemes of arrangement (Schemes) between